|
|
|
40
|
A8317
|
MOBIC 15MG TAB (BOE/STO) MELOXICAM
|
MELOXICAM
|
MOBIC
|
30'S
|
C
|
41.59
|
1.39
|
TABLET
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A831AK
|
APO-MELOXICAM 7.5MG TAB (APO)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
4.62
|
0.05
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
A831AN
|
APO-MELOXICAM 15MG TAB (APO/COL)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
7.61
|
0.08
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28080408
|
CYCLOOXYGENASE-2 (COX2) INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A831AN
|
APO-MELOXICAM 15MG TAB (APO)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
7.77
|
0.08
|
TAB
|
15
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831AZ
|
MELOXICAM 15MG TAB (HEA) (C)
|
MELOXICAM
|
MELOXICAM
|
10'S
|
C
|
0.71
|
0.0707
|
TAB
|
15
|
BOTT
|
HEA
|
HEALTH 2000 INC
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FM
|
APO-MELOXICAM 7.5MG TAB (APO) (C)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
4.62
|
0.0462
|
TAB
|
0
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
A831FN
|
APO-MELOXICAM 15MG TAB (APO) (C)
|
MELOXICAM
|
APO-MELOXICAM
|
100'S
|
C
|
7.77
|
0.0777
|
TAB
|
15
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28080492
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|